BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 33174005)

  • 1. In vitro anti‑bacterial activity of diosgenin on Porphyromonas gingivalis and Prevotella intermedia.
    Cong S; Tong Q; Peng Q; Shen T; Zhu X; Xu Y; Qi S
    Mol Med Rep; 2020 Dec; 22(6):5392-5398. PubMed ID: 33174005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative evaluation of the antimicrobial susceptibility and cytotoxicity of husk extract of
    Kohli D; Hugar SM; Bhat KG; Shah PP; Mundada MV; Badakar CM
    J Indian Soc Pedod Prev Dent; 2018; 36(2):142-150. PubMed ID: 29970631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory effects of lactoferrin on growth and biofilm formation of Porphyromonas gingivalis and Prevotella intermedia.
    Wakabayashi H; Yamauchi K; Kobayashi T; Yaeshima T; Iwatsuki K; Yoshie H
    Antimicrob Agents Chemother; 2009 Aug; 53(8):3308-16. PubMed ID: 19451301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial susceptibilities of Porphyromonas gingivalis, Prevotella intermedia, and Prevotella nigrescens spp. isolated in Spain.
    Andrés MT; Chung WO; Roberts MC; Fierro JF
    Antimicrob Agents Chemother; 1998 Nov; 42(11):3022-3. PubMed ID: 9797247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro Resistance Testing of Porphyromonas gingivalis, Prevotella intermedia, and Tannerella forsythia to Triclosan.
    Farsi D; Tanner A
    J Contemp Dent Pract; 2016 Apr; 17(4):282-5. PubMed ID: 27340161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of antibacterial peptide activity by products of Porphyromonas gingivalis and Prevotella spp.
    Devine DA; Marsh PD; Percival RS; Rangarajan M; Curtis MA
    Microbiology (Reading); 1999 Apr; 145 ( Pt 4)():965-971. PubMed ID: 10220176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the antimicrobial effect of lactoferrin on Porphyromonas gingivalis, Prevotella intermedia and Prevotella nigrescens.
    Aguilera O; Andrés MT; Heath J; Fierro JF; Douglas CW
    FEMS Immunol Med Microbiol; 1998 May; 21(1):29-36. PubMed ID: 9657318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Sodium Tripolyphosphate on Oral Commensal and Pathogenic Bacteria.
    Moon JH; Noh MH; Jang EY; Yang SB; Kang SW; Kwack KH; Ryu JI; Lee JY
    Pol J Microbiol; 2019; 68(2):263-268. PubMed ID: 31257792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metronidazole susceptibility testing of anaerobic bacteria associated with periodontal disease.
    Poulet PP; Duffaut D; Lodter JP
    J Clin Periodontol; 1999 Apr; 26(4):261-3. PubMed ID: 10223399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraspecies Variability Affects Heterotypic Biofilms of Porphyromonas gingivalis and Prevotella intermedia: Evidences of Strain-Dependence Biofilm Modulation by Physical Contact and by Released Soluble Factors.
    Barbosa GM; Colombo AV; Rodrigues PH; Simionato MR
    PLoS One; 2015; 10(9):e0138687. PubMed ID: 26406499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production and sensitivity of bacteriocin-like activity among Porphyromonas gingivalis, Prevotella intermedia and Pr. nigrescens strains isolated from periodontal sites.
    Teanpaisan R; Baxter AM; Douglas CW
    J Med Microbiol; 1998 Jul; 47(7):585-9. PubMed ID: 9839562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial profiles of periodontal pathogens isolated from periodontitis patients in The Netherlands and Spain.
    van Winkelhoff AJ; Herrera D; Oteo A; Sanz M
    J Clin Periodontol; 2005 Aug; 32(8):893-8. PubMed ID: 15998275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibacterial Efficacy of
    Mendoza R; Alvitez-Temoche D; Chiong L; Silva H; Mauricio F; Mayta-Tovalino F
    J Contemp Dent Pract; 2023 Aug; 24(8):551-555. PubMed ID: 38193176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dipeptide utilization by the periodontal pathogens Porphyromonas gingivalis, Prevotella intermedia, Prevotella nigrescens and Fusobacterium nucleatum.
    Takahashi N; Sato T
    Oral Microbiol Immunol; 2002 Feb; 17(1):50-4. PubMed ID: 11860556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Periodontitis, periodontopathic bacteria and lactoferrin.
    Wakabayashi H; Kondo I; Kobayashi T; Yamauchi K; Toida T; Iwatsuki K; Yoshie H
    Biometals; 2010 Jun; 23(3):419-24. PubMed ID: 20155438
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Kawai T; Ohshima T; Tanaka T; Ikawa S; Tani A; Inazumi N; Shin R; Itoh Y; Meyer K; Maeda N
    Front Cell Infect Microbiol; 2022; 12():804334. PubMed ID: 35321313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial activity of silver nitrate against periodontal pathogens.
    Spacciapoli P; Buxton D; Rothstein D; Friden P
    J Periodontal Res; 2001 Apr; 36(2):108-13. PubMed ID: 11327077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Occurrence of Actinobacillus actinomycetemcomitans, Porphyromonas gingivalis, and Prevotella intermedia in progressive adult periodontitis.
    López NJ
    J Periodontol; 2000 Jun; 71(6):948-54. PubMed ID: 10914798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibacterial activity of [10]-gingerol and [12]-gingerol isolated from ginger rhizome against periodontal bacteria.
    Park M; Bae J; Lee DS
    Phytother Res; 2008 Nov; 22(11):1446-9. PubMed ID: 18814211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antibacterial effect of the carboxymethyl chitosan zinc peptide on several periodontal pathogens in vitro].
    Song J; Deng J; Wu Y; Liu W; Song F
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2015 Jul; 50(7):413-7. PubMed ID: 26564745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.